Avid Bioservices Inc (CDMO)

[biopharm]

I wonder if Dr. Parsa realized the potential of PS Targeting

So now I see top 2 immunotherapy top researchers in their fields both pass at such a young age and ANYONE going into immunotherapy since 2012 knows very well the potential of PS Targeting

Brain surgeon Dr. Andrew Parsa dies at 48

2015

Dr. Andrew Parsa combined intellect, skill and a kind bedside manner, a blend some say is rarely found in surgeons.

Dr. Parsa, the chair of neurological surgery at the Feinberg School of Medicine and Northwestern Memorial Hospital, died unexpectedly Monday at his Lincoln Park home, relatives said. He was 48. A cardiac problem may have been the cause, said his brother, Tim.

He performed 300 operations a year and mentored young physicians. He researched ways to unleash the body’s immune system to fight brain cancer. And he was the chief investigator in the biggest randomized trial funded by the National Cancer Institute on a potential brain tumor vaccine, according to the Feinberg School.

He was “a luminary on the surgery front,” his brother said, “helping patients that are in dire straits, and helping them recover in the hardest, scariest juncture of their lives. And he would do that 300 times a year. Trying to cure the disease, he worked on efforts to find a vaccine. At the same time, he was a dedicated father raising three kids, and a dedicated husband.”

“He was extraordinarily approachable,” said his sister, Dr. Tania Parsa. “He wasn’t talking over you. He was talking to you.”

He gave patients his cellphone number and knew the names of everyone from the operating room staff to security guards, according to a story in Northwestern Medicine Magazine.

..

http://chicago.suntimes.com/news/7/71/518252/dr-andrew-parsa-northwestern-hospital-surgeon-dies-48

-----------------